Professor John Greenman J.Greenman@hull.ac.uk
Professor of Tumour Immunology
Development of an immune-responsive 3D skin model
People Involved
Project Description
The immune system is an essential regulator of normal physiologic and wound repair processes within the skin, and it contributes to the progression of many different skin diseases. The nature of the interactions between circulating immune cells and resident skin cells is highly complex and currently difficult to model in the lab. While animal models are able to capture much of this complexity, they often fail to accurately replicate human-specific responses. There is therefore a clear need to develop more advanced human skin models that include essential immune responses. The aim of this sabbatical project is to carry out preliminary studies for the development of next-generation, immune-competent skin models. The proposed model will consist of 3D human skin equivalents linked to an immune cell compartment through a perfusable culture system. The planned project will involve a three-month research exchange, where a research assistant from QMUL with expertise in 3D skin models will work with immunology experts at the University of Hull. Existing 3D skin models will be incorporated into a commercially available, perfusable culture system and combined with immune cells. As a proof-of-concept, the immune response to a common skin irritant will be examined within this model system. The successful completion of this project will establish a new collaboration, generate essential preliminary data for future grant applications, and build the research capacity of the Organ-on-a-Chip network.
Status | Project Complete |
---|---|
Funder(s) | Queen Mary University of London |
Value | £2,900.00 |
Project Dates | May 1, 2019 - Jul 31, 2019 |
You might also like
Blood test for clinical therapy guidance of non-small cell lung cancer patients Jan 1, 2017 - Oct 31, 2022
Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSCLC patients for EGFR mutations (pharmacogenomics) for treatment decision (personalised medicine) – i.e., patie...
Read More about Blood test for clinical therapy guidance of non-small cell lung cancer patients.
The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture. Jun 1, 2017 - May 31, 2018
Graves’ disease (GD) affects approximately 2% of adult women. Current treatments for GD include anti-thyroid drugs, radioiodine therapy and surgery, of which none tackle the underlying pathogenic process. Immunosuppressive agents are therefore of gro...
Read More about The effect of corticosteroids on the release of immune modulating factors from Graves’ disease tissue maintained using microfluidic culture..
Development of a multipurpose small animal phantom for pre-clinical radiotherapy studies Apr 1, 2016 - Mar 31, 2019
The project aims to both reduce the total number of animals used for preclinical radiotherapy experiments whilst concurrently increasing the accuracy of such investigations in order to maximise their clinical impact. This will be achieved through the...
Read More about Development of a multipurpose small animal phantom for pre-clinical radiotherapy studies.
The Hull-Norwich Gut-Brian Study May 31, 2016 - Jun 30, 2018
Objective To obtain mechanistic insights into how resident commensal gut bacteria (the microbiota) influences host physiology and in particular brain function and host behaviour. The focus is on identifying the pathways and molecules originating from...
Read More about The Hull-Norwich Gut-Brian Study.
Lab on a Chip NC3Rs Engagement Award Aug 15, 2016 - Aug 14, 2017
This project will deliver a programme of public engagement with innovative hands-on activities in the area of tissue/organ-on-a-chip which are emerging as life-like models to reduce and replace animal testing to school children and the general public...
Read More about Lab on a Chip NC3Rs Engagement Award.